Sponsor Pipeline

Elpiscience (Suzhou) Biopharma, Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
2
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-09 NCT05167448
A Study of ES104 in Patients With Metastatic Colorectal Cancer		 overall status: Active, Not Recruiting → Unknown
Active Trials by Phase
Phase 2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06623136 A Study of ES102 in Combination With Toripalimab in Subjects With Advanced Non-small Cell… Non-Small Cell Lung Cancer Recruiting
NCT07541430 A Study in Adults With Desmoid Tumors Desmoid Tumor Recruiting
Phase 1
NCT05717348 A Study of ES014 in Patients With Locally Advanced or Metastatic Solid Tumours Solid Tumor Active, Not Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1)
Get alerts when Elpiscience (Suzhou) Biopharma, Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free